by Karen Faulkner, Worthy News Correspondent

(Worthy News) – After four decades of developing chemical weapons for use against its enemies, Iran’s Islamic terror regime may now have supplied its proxies, including Hamas and Hezbollah, with pharmaceutical-based agents (PBAs) that attack a person’s central nervous system, the US’ Westpoint Combating Terrorism Center (CTC) warns in a new report.

The issue is of particular concern to Israel which is fighting not only Hamas in Gaza and Hezbollah in Lebanon but has also fielded ballistic missile attacks from Iran in the last year.

In its October 24, 2024 report titled “Tehran’s Tactical Knockout: Weaponized Pharmaceutical-Based Agents,” the CTC states that US officials assess that Tehran is in non-compliance with its Chemical Weapons Convention (CWC) obligations, particularly in its development of PBAs as part of a chemical weapons program.

“Over time, concern about this program has increased, with reports to the Organisation for the Prevention of Chemical Weapons (OPCW), statements by multilateral groups such as the G7, and a variety of U.S. government reports and sanctions,” the CTC explains.

“Today, with Iran’s proxies wreaking havoc throughout the region, officials worry Tehran may have already provided weaponized PBAs to several of its partners and proxies, the CTC warns. Such a capability, tactically deployed on the battlefield, could enable further October 7-style cross-border raids or kidnapping operations.”

Noting that Israel is particularly vulnerable to a chemical weapons attack, the CTC states: “With the region on edge following the targeted killing of Hezbollah leader Hassan Nasrallah, followed by an Israeli ground campaign targeting Hezbollah infrastructure along the border, and the Iranian ballistic missile attack on Israel, concern about the use of such tactical chemical weapons is high.”

Copyright 1999-2024 Worthy News. This article was originally published on Worthy News and was reproduced with permission.

Latest Stories from Worthy News